Skip to main content

Lung Cancer

Beyond Smoking, Lung Cancer Drivers Include Pollution and Genetics


Amid growing recognition of factors that contribute to lung cancer risk, it’s time to think beyond smoking, according to speakers at a session of the 2024 World Conference on Lung Cancer. These factors range from the air in our homes to the makeup of our DNA, and smart policy solutions and mitigation strategies are critical.

First, Joan Schiller, MD, of the Lung Cancer Research Foundation in Virginia, discussed the role of outdoor air pollution in lung cancer. Air pollution from burning fossil fuels is largely discussed in terms of its respiratory and cardiac effects, but it’s also a significant cause of lung cancer and accounts for an estimated 14% of lung cancer–related deaths, Schiller said. The fine particulate matter known as PM2.5 is especially insidious, as it infiltrates the bronchioles and alveolar cells and causes systemic effects. A 10 mcg/m3 increase in PM2.5 is associated with an HR for lung cancer of 1.13, and for never-smokers the HR rises to 1.73.1 Another lung cancer risk factor in the air around us is pollution from wildfires, which are becoming more frequent, more intense, and longer lasting, and their PM2.5 carries more carbon and thus greater oxidative potential.

What can individuals do to combat the effects of outdoor air pollution? Personal actions like reducing use of gas-powered vehicles are great, but those in the room also need to make their voices heard to enact change.

“As health care representatives, we are powerful messengers, and as cancer care professionals, we are very powerful messengers,” Schiller said.

Although genetics are impossible to change, there’s still an advocacy role to be played by the lung cancer community in expanding access to genomic testing, according Andres Cardona, PhD, of Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center in Colombia. Mutation frequency differs across ancestry, and pathogenic germline variants are thought to increase lung cancer risk.

Recent research has shown the prevalence of these variants in cohorts such as Hispanic patients with lung adenocarcinoma, especially male and younger patients,2 as well as evidence that carriers of a germline EGFR mutation had longer duration of therapy on osimertinib.3

Ancestry affects not only the molecular epidemiology of the disease, it could also influence pharmacogenomics in patients with oncogenic drivers, and more research is needed. “Although we are all human, we and our diseases are completely different,” he concluded.

Next, Laura Mezquita, MD, PhD, of the Hospital Clinic in Barcelona, Spain, discussed the role of indoor pollutants like radon, a radioactive gas that comes from soil and is associated with 3% to 14% of lung cancer cases. A radon level of 300 Bq/m3, which is the European Union’s reference level, carries the radiation dose equivalent of 274 chest x-rays per year. The specific mechanisms by which it contributes to lung cancer are not fully understood, but given its known DNA-damaging effects, health agencies are striving to spread awareness of the need to measure and mitigate radon in the home.

Other indoor pollutants include secondhand tobacco smoke and vapor, marijuana smoking, and cooking fumes or oil. But Mezquita emphasized that most patients are exposed to not just a single risk factor but several, and we need more research on the shared mechanisms among carcinogens. She and colleagues are now conducting a prospective study on the lung cancer exposome and how the combination of carcinogens and endogenous factors impact quality of life, response to treatment, and survival, in hopes that “with these kinds of multidisciplinary collaborations, we can provide more detailed information and better understanding about the role of these risk factors in lung cancer and to identify the specific groups at risk.”

Finally, Isabelle Soerjomataram, MD, PhD, of the International Agency for Research on Cancer in France, discussed the role of policies to prevent lung cancer by addressing factors other than smoking and how they must be tailored to the prevalent pollution sources and cultural context of each country.

Successful strategies include London’s congestion charge, which saw air pollution decrease after charging a £15 fee to drive in a congested region of the city. The policy was initiated more as a traffic control measure than a health intervention, but Soerjomataram anticipates positive impacts on health and well-being, along with increased revenue for the city that can be reinvested into public transit.

There are many instruments available that policy makers can leverage to reduce air pollution—not just financial as in London’s case but also including regulation, infrastructure, technology, and the built environment. But they must keep a careful eye on any unintended consequences, such as when a law in Indonesia requiring cars to have at least 3 passengers led to drivers hiring children just to sit in a car.

 lung cancer, smoking, pollution, genetics, environmental factors, particulate matter, PM2.5, carcinogens, industrial emissions, genetic predisposition, EGFR mutations, KRAS mutations, non-smokers, personalized treatment, genetic screening, hereditary risk, air quality, carcinogenic pollutants, cancer prevention, public health,

#LungCancer, #Smoking, #Pollution, #Genetics, #EnvironmentalFactors, #PM25, #Carcinogens, #IndustrialEmissions, #GeneticMutations, #EGFR, #KRAS, #NonSmokers, #PersonalizedTreatment, #GeneticScreening, #HereditaryRisk, #AirQuality, #CarcinogenicPollutants, #CancerPrevention, #PublicHealth, #Research

International Conference on Genetics and Genomics of Diseases 




For Enquiries: genetics@healthcarek.com 

Get Connected Here 
--------------------------------- 
--------------------------------- 

Comments

Post a Comment

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...
Post a Comment
Read more